Xin Yi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Coronary Artery

Top Venues

Circulation research

Disease markers

Oxidative medicine and cellular longevity

Cell proliferation

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Li, Xiang Wei, Rui Xiao, YongJie Chen, Xiong Tianxin, Ze-Min Fang, Bo Huo, Xian Guo, Hanshen Luo, Xingliang Wu, Liyuan Liu, Xue-Hai Zhu, Qinghua Hu, Ding-Sheng Jiang, Xin Yi
SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy. Circulation research (2024)
Yi Li, Xiang Wei, Rui Xiao, Yongjie Chen, Tianxin Xiong, Ze-Min Fang, Bo Huo, Xian Guo, Hanshen Luo, Xingliang Wu, Liyuan Liu, Xue-Hai Zhu, Qinghua Hu, Ding-Sheng Jiang, Xin Yi
SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy. Circulation research 135 (1) (2024)
Yi Li, Xiang Wei, Rui Xiao, Yongjie Chen, Tianxin Xiong, Ze-Min Fang, Bo Huo, Xian Guo, Hanshen Luo, Xingliang Wu, Liyuan Liu, Xue-Hai Zhu, Qinghua Hu, Ding-Sheng Jiang, Xin Yi
SMYD2-Methylated PPARγ Facilitates Hypoxia-Induced Pulmonary Hypertension by Activating Mitophagy. Circulation research 135 (1) (2024)
Ze-Min Fang, Shu-Min Zhang, Hanshen Luo, Ding-Sheng Jiang, Bo Huo, Xiaoxuan Zhong, Xin Feng, Wenlin Cheng, Yue Chen, Gaoke Feng, Xingliang Wu, Fang Zhao, Xin Yi
Methyltransferase-like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation. Cell proliferation (2022)
Peijiang Lu, Xin Feng, Rui Li, Peng Deng, Shiliang Li, Jiewen Xiao, Jing Fang, Xingyu Wang, Chang Liu, Qiuxia Zhu, Jing Wang, Zemin Fang, Lu Gao, Sen Guo, Xue-Jun Jiang, Xue-Hai Zhu, Tingting Qin, Xiang Wei, Xin Yi, Ding-Sheng Jiang
A Novel Serum Biomarker Model to Discriminate Aortic Dissection from Coronary Artery Disease. Disease markers 2022 (2022)
Xin Yi, Qiu-Xia Zhu, Xing-Liang Wu, Tuan-Tuan Tan, Xue-Jun Jiang
Histone Methylation and Oxidative Stress in Cardiovascular Diseases. Oxidative medicine and cellular longevity 2022 (2022)